$ARIA Company News Apple closes lower; B. of A. rises on

New Post Public Reply Private Reply Replies (0) Message Board

Jan 7, 2014 at 3:26 PM

$ARIA Company News

Apple closes lower; B. of A. rises on analyst call 4:15 p.m. Jan. 2, 2014 - Wallace Witkowski
Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy

ARIAD to Present at JPM Conference - Analyst Blog 6:00 p.m. Jan. 6, 2014 - Zacks.com
UPDATE: Ariad Pharmaceuticals Downgraded by Citigroup 10:42 a.m. Jan. 6, 2014 - benzinga.com
Citi negative on Sarepta, Ariad for 2014, shares slide 8:21 a.m. Jan. 6, 2014 - Seeking Alpha
Top Analyst Downgrades, Stocks to Sell: Apple, Twitter, First Solar and More 7:53 a.m. Jan. 6, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:19 a.m. Jan. 6, 2014 - benzinga.com
A Strange Mix of Action 4:44 p.m. Jan. 3, 2014 - RealMoney.com
Patience and Prudence 10:39 a.m. Jan. 3, 2014 - RealMoney.com
Biotech Stock Mailbag: Inovio, Chelsea, Exelixis, Ariad, ImmunoCellular 8:00 a.m. Jan. 3, 2014 - TheStreet.com
Ariad rallies, company to present at conference 1:37 p.m. Jan. 2, 2014 - Seeking Alpha
Benzinga's Top #PreMarket Gainers 7:12 a.m. Jan. 2, 2014 - benzinga.com
ARIAD to Present at JP Morgan Healthcare Conference on Tuesday, January 14 at 6:00 PM ET 6:39 a.m. Jan. 2, 2014 - benzinga.com
Can The Uptrend Continue for Ariad Pharmaceuticals, Inc. (ARIA)? - Tale of the Tape 8:41 a.m. Dec. 31, 2013 - Zacks.com
Mid-Day Market Update: US Markets Turn Lower; Twitter Shares Fall On Analyst Downgrade 12:46 p.m. Dec. 27, 2013 - benzinga.com
Mid-Morning Market Update: Markets Mostly Higher; Textron To Acquire Beechcraft For $1.4B 10:19 a.m. Dec. 27, 2013 - benzinga.com
Ariad Revenue Boosted by Iclusig 12:45 a.m. Dec. 27, 2013 - Barrons.com
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Dec. 26, 2013 - TheStreet.com
Update on ARIAD's Iclusig - Analyst Blog 4:45 p.m. Dec. 26, 2013 - Zacks.com
5 Biotechnology Stocks to Buy Now 2:00 a.m. Dec. 25, 2013 - InvestorPlace.com
Ariad Pharmaceuticals (ARIA) Catches Eye: Stock Jumps 8.9% - Tale of the Tape 9:32 a.m. Dec. 24, 2013 - Zacks.com
Credit Suisse raises target but still cautious on Ariad Pharma 1:02 p.m. Dec. 23, 2013 - Seeking Alpha

Conferences, Completed Acquisitions, and Stock Price Movements - Research Report on Ariad, Salix, Molina, Mednax, and Merrimack 8:00 a.m. Today - PR Newswire
Morning Buzzers: Apple Inc, Plug Power Inc, Ariad Pharmaceuticals, Biodel Inc 10:01 a.m. Jan. 3, 2014 - ACCESSWIRE
ARIAD to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:34 a.m. Jan. 2, 2014 - BusinessWire
FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Ariad Pharmaceuticals, Inc. -- ARIA 6:28 p.m. Dec. 3, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Quanta Services Reports Record Q3 2026 Earnings

Quanta Services Smashes Q3 2026 Expectations If you're a stakeholder in Quanta Services, you'd probably be dancing in the aisles right now. This company just posted off-the-charts numbers for the third quarter of 2026. We're talking revenues of $12 billion—a staggering leap from $7.63 billion the same quarter last year. Explosive Earnings and Strong Backlog The star of...

Faith on Trial: La Luz del Mundo Faces Court Ruling

A Legal Battle Over Religious Freedom When folks start talking about religion intertwining with law, things get real tricky, real quick. The La Luz del Mundo church is knee-deep in such a legal tussle. On October 28, 2026, the United States District Court for the Southern District of New York gave a nod to the prosecution, denying the church's pretrial motions. What we've...

2026 Data Integration Stars: User Sentiments Revealed

Users Crown Data Integration Champions Right out of the gate, let's make one thing clear: when you're picking a data integration solution, you're essentially hitching your wagon to a vendor. This partnership, like any, can make or break your operations, and no one knows this better than the folks who've been through the trenches. Enter Infotech's 2026 Emotional Footprint...

Banco Macro S.A. Plans $160B Share Buyback Initiative

Tapping into Share Buybacks in a Tumultuous Market Out of nowhere, Banco Macro S.A. has decided to whip up a share buyback program, a lifeline for their current market value. Let me tell you, the market's more volatile than a caffeinated squirrel these days, hitting the financial scenery harder than a hammer on a glass table. So, Banco Macro's taken a deep breath and...

Smartpress: Adobe & Canva Shape Print Design World

Adobe's Stranglehold on Professional Design Over at Smartpress, they've pulled the curtain back on just how heavily Adobe Creative Suite weighs in on the print design sector. The company's recent analysis shines a light on the staggering 66% dominance of Adobe's InDesign and Illustrator in file submissions. That's a hefty portion influencing both the quality and financial...

Atlantic Blvd Apartments: A Game-Changer for Housing

A Bold Move for Attainable Housing Amidst the hustle and bustle of Sterling, Virginia, a new player has hit the scene: Atlantic Blvd Apartments. A property designed solely for attainable housing, this development is a showcase of what can be accomplished when local government and private developers team up with a shared vision. It feels like a breath of fresh air in a...

Data Breach at Lumara Bio: Privacy Lawsuits Loom

Another Day, Another Data Breach It seems like you can’t throw a stone without hitting a data breach these days—and this time, it’s Lumara Bio USA’s turn under the spotlight. The Princeton-based oncology therapeutics outfit, part of Germany’s ITM Isotope Technologies, spilled some beans it never meant to. We're talking some pretty sensitive stuff here, folks....

Clip Expands Horizons with Pulpos Acquisition, New Board Member

Clip's Strategic Move with Pulpos Clip just laid down a serious marker in the digital payment world by snagging Pulpos, a firm that’s got its claws deep into AI-driven business management software. This move isn't just some fancy headline. It's a real, grounded step in expanding Clip's ecosystem to bolster the backbone of Mexico's economy: small and medium-sized...

Infection Control Market Set for Explosive Growth by 2031

Untangling the Surge in Infection Control Demand Lately, it's like every healthcare joint worldwide is scrambling for better infection control. We're talking about a market poised to jump from a whopping USD 58.5 billion in 2026 to USD 80.2 billion by 2031—a tidy 37% uptick. That change, brewing at a 6.5% CAGR, speaks volumes about where the industry's heading. What's...

Genefluence Launches Rapid UTI PCR Test at Chelsea Hospital

There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....